Adamas Pharmaceuticals (ADMS) 10-Q 2018 Q2 Quarterly report

Exhibit 10.1

NON-EMPLOYEE DIRECTOR COMPENSATION

Cash Compensation

The annual cash compensation payable to non-employee directors of Adamas Pharmaceuticals, Inc. is as follows, payable quarterly in arrears:

Retainer		Amount
Board Member Compensation
	Annual Board Member	$40,000
	Additional Lead Independent Director	$22,500
Additional Committee Chair Compensation
	Audit Committee	$20,000
	Compensation Committee	$14,000
	Nominating and Corporate Governance Committee	$10,000
Additional Committee Member (non-Chair) Compensation
	Audit Committee	$10,000
	Compensation Committee	$7,000
	Nominating and Corporate Governance Committee	$5,000

Equity Compensation

Non-employee directors also receive an initial equity award upon commencement of service as a board member; thereafter, each non-employee director will receive an annual equity grant on the date of the Adamas Pharmaceuticals, Inc. annual meeting. The form of award in each case is a non-qualified stock option. The initial award is an option to purchase 20,000 shares of Adamas Pharmaceuticals, Inc. common stock that will vest annually over three years of service. Each subsequent annual award is an option to purchase 10,000 shares of Adamas Pharmaceuticals, Inc. common stock that will vest after one year of service. Additionally, upon the closing of a change of control, the vesting of all outstanding equity awards held by non-employee directors will accelerate in full.